Navigation Links
Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
Date:7/16/2008

Vertos Medical Inc, a privately held medical device manufacturer focusing on minimally invasive treatment of lumbar spinal stenosis (LSS), announced presentation of its clinical results of its proprietary Minimally Invasive Lumbar Decompression, MILD™, procedure. The MILD procedure, is a simple, percutaneous, fluoroscopically guided treatment for central canal Lumbar Spinal Stenosis,(LSS). MILD can be performed under local anesthesia and substantially reduces the tissue damage and tissue removal associated with other minimally invasive or open surgeries. LSS is diagnosed in 1.5 million Americans each year. Vertos has obtained FDA clearance for sale of the MILD devices in the USA.

San Jose CA (PRWEB) July 16, 2008 -- Vertos Medical Inc, a privately held medical device manufacturer focusing on minimally invasive treatment of lumbar spinal stenosis (LSS), announced presentation of its clinical results of its proprietary Minimally Invasive Lumbar Decompression, MILD™, procedure. The MILD procedure, is a simple, percutaneous, fluoroscopically guided treatment for central canal Lumbar Spinal Stenosis,(LSS). MILD can be performed under local anesthesia and substantially reduces the tissue damage and tissue removal associated with other minimally invasive or open surgeries. LSS is diagnosed in 1.5 million Americans each year. Vertos has obtained FDA clearance for sale of the MILD devices in the USA.

Clinical results on 32 patients with moderate to severe LSS have shown that all patients were discharged either the same day or the day following the MILD™ procedure. These patients were treated at 11 medical centers of excellence. No complications or adverse events were reported.

Clinical results included a 90% decrease in pain as measured by the Visual Analog Scale (VAS), as well as improved mobility, represented by a decrease in the Oswestry Disability Index (ODI) of 84%. All patients reported had discontinued the use of narcotics or pain medication at 6 weeks following the MILD procedure.

These results were presented at the recently held Spine Technology Education Group's 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos by Jonathan Hyde MD, a leading spine surgeon. Dr Hyde practices at Mount Sinai Medical Center in Miami Beach, Florida.

"The clinical results presented in Los Cabos are very encouraging and mirror the results the patients I treated in my practice in Miami. The MILD™ procedure certainly offers a minimally invasive alternative to open surgery with short recovery and rehabilitation times" said Jonathan Hyde MD. Richard Johnson MD, Vertos President and CEO added "LSS affects 1.5 million Americans each year. The MILD™ procedure will offer many of these patients a minimally invasive alternative to invasive open surgery, with shorter procedure, hospitalization and rehab times. We are very pleased and encouraged by the clinical results Dr. Hyde presented"

For further information, please contact Herbert Mertens via email at hmertens(at)vertosmed.com or via telephone at (619)602-0061.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. North Carolinas Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center
2. Medical And Nursing Scrubs Retailer Blue Sky Scrubs Unveils New Website
3. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
4. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
5. Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
6. Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc.
7. The Five Biggest Marketing Mistakes Made By Medical Offices and Small Businesses
8. Medical Devices Get Most Funding in Slow Stretch for VC: Mid-Year Results from Healthcare Corporate Finance News
9. VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29
10. Surgeons Use USGI Medicals EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference
11. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... February 13, 2016 , ... Good news ... first in the area to offer AngioPlex™ Optical Coherence Tomography (OCT) Angiography, imaging ... as macular degeneration, diabetic retinopathy, and other vascular conditions. , In just a ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... With FCPX ... overlays to footage all within Final Cut Pro X. Each user can select from ... 3D rotation, angle of view, blur, focus offset, hue, saturation, value, contrast, glow, and ...
(Date:2/13/2016)... ... ... In the early or “honeymoon” stage of a relationship, couples strive to ... way to be romantic, and may exaggerate a strength or two in an effort ... , A recent study from Queendom.com , however, suggests that new couples ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to ... students from U.S. universities who will draw from Siemens’ deep knowledge of ...
(Date:2/12/2016)... ... February 12, 2016 , ... As a former television executive, owner Tal Rabinowitz ... no time to decompress, Rabinowitz found herself drawn to a casual meditation class while ... on her life, implementing a 20-minute-per-day meditation practice with her team. After her tenure ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... ALEXANDRIA, Va. , Feb. 12, 2016  This ... & Specialty Pharmacy (JMCP) takes an in-depth look ... the recent spike in prescription drug spending, which has ... JMCP Editor-in-Chief Laura E. Happe ... Laura E. Happe , PharmD, MPH. --> ...
(Date:2/12/2016)... , February 12, 2016 /PRNewswire/ ... nicht anders vermerkt)   http://www.sedar.com ... http://www.telestatherapeutics.com abrufbar.    --> ... des Unternehmens http://www.telestatherapeutics.com abrufbar.    ... (TSX:TST; PNK:BNHLF) veröffentlichte heute seinen Konzernabschluss des ...
(Date:2/12/2016)... VIEJO, Calif. , Feb. 12, 2016  Sequent ... enrollment in a study to evaluate the safety and ... for the treatment of ruptured intracranial aneurysms.  Prof ... University Hospital, in Paris, France ... first patient. France and ...
Breaking Medicine Technology: